127 related articles for article (PubMed ID: 8309263)
1. Relative value of transdermal and oral estrogen therapy in various clinical situations.
Lufkin EG; Ory SJ
Mayo Clin Proc; 1994 Feb; 69(2):131-5. PubMed ID: 8309263
[TBL] [Abstract][Full Text] [Related]
2. Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy.
Laliberté F; Dea K; Duh MS; Kahler KH; Rolli M; Lefebvre P
Menopause; 2018 Nov; 25(11):1297-1305. PubMed ID: 30358726
[TBL] [Abstract][Full Text] [Related]
3. [Basic principles of hormone replacement therapy in the postmenopause].
Dören M
Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
[TBL] [Abstract][Full Text] [Related]
4. Are all estrogens created equal? A review of oral vs. transdermal therapy.
Goodman MP
J Womens Health (Larchmt); 2012 Feb; 21(2):161-9. PubMed ID: 22011208
[TBL] [Abstract][Full Text] [Related]
5. Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy.
Laliberté F; Dea K; Duh MS; Kahler KH; Rolli M; Lefebvre P
Menopause; 2011 Oct; 18(10):1052-9. PubMed ID: 21775912
[TBL] [Abstract][Full Text] [Related]
6. Changes in hemostatic variables induced by estrogen replacement therapy: comparison of transdermal and oral administration in a crossover-designed study.
Fait T; Vrablik M; Zizka Z; Kostirova M
Gynecol Obstet Invest; 2008; 65(1):47-51. PubMed ID: 17713346
[TBL] [Abstract][Full Text] [Related]
7. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
Ichikawa J; Sumino H; Ichikawa S; Ozaki M
Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism and cardiovascular disease complications in menopausal women using transdermal versus oral estrogen therapy.
Simon JA; Laliberté F; Duh MS; Pilon D; Kahler KH; Nyirady J; Davis PJ; Lefebvre P
Menopause; 2016 Jun; 23(6):600-10. PubMed ID: 26953655
[TBL] [Abstract][Full Text] [Related]
9. The impact of dose and route of estrogen administration on the somatotropic axis in normal women.
Lissett CA; Shalet SM
J Clin Endocrinol Metab; 2003 Oct; 88(10):4668-72. PubMed ID: 14557438
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the impact of transdermal versus oral estrogens on biliary markers of gallstone formation in postmenopausal women.
Uhler ML; Marks JW; Voigt BJ; Judd HL
J Clin Endocrinol Metab; 1998 Feb; 83(2):410-4. PubMed ID: 9467549
[TBL] [Abstract][Full Text] [Related]
11. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
Ettinger B; Pressman A; Bradley C
Menopause; 1998; 5(3):152-6. PubMed ID: 9774760
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of estrogen.
Stumpf PG
Obstet Gynecol; 1990 Apr; 75(4 Suppl):9S-14S; discussion 15S-17S. PubMed ID: 2179793
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women.
O'Sullivan AJ; Ho KK
J Clin Endocrinol Metab; 1995 Jun; 80(6):1783-8. PubMed ID: 7775623
[TBL] [Abstract][Full Text] [Related]
14. Alternatives to oral estrogen replacement. Transdermal patches, percutaneous gels, vaginal creams and rings, implants, other methods of delivery.
Baker VL
Obstet Gynecol Clin North Am; 1994 Jun; 21(2):271-97. PubMed ID: 7936545
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk in postmenopausal women using estrogen-only therapy.
Lyytinen H; Pukkala E; Ylikorkala O
Obstet Gynecol; 2006 Dec; 108(6):1354-60. PubMed ID: 17138766
[TBL] [Abstract][Full Text] [Related]
16. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
17. A review of transdermal nonpatch estrogen therapy for the management of menopausal symptoms.
Carroll N
J Womens Health (Larchmt); 2010 Jan; 19(1):47-55. PubMed ID: 20088658
[TBL] [Abstract][Full Text] [Related]
18. Comparison of effects of continuous combined transdermal with oral estrogen and oral progestogen replacement therapies on serum lipoproteins and compliance.
Erenus M; Karakoç B; Gürler A
Climacteric; 2001 Sep; 4(3):228-34. PubMed ID: 11588947
[TBL] [Abstract][Full Text] [Related]
19. Type and route of estrogen administration.
Stevenson JC
Climacteric; 2009; 12 Suppl 1():86-90. PubMed ID: 19811249
[TBL] [Abstract][Full Text] [Related]
20. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk.
Scarabin PY; Oger E; Plu-Bureau G;
Lancet; 2003 Aug; 362(9382):428-32. PubMed ID: 12927428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
